JPMorgan Chase executive Lake Marianne reported an open-market sale of 3,907 shares of common stock at $306.4137 per share. The transaction was executed on February 17, 2026 through Grantor Retained Annuity Trusts, which hold 137,299 shares indirectly after the sale.
Separately from these GRAT holdings, she is shown with 48,017 shares held directly and 64,271 shares held indirectly through a Family Trust. Footnote disclosures explain earlier February 2026 transfers among a GRAT, a Family Trust, and the Grantor that were treated as exempt under Rule 16a-13.
JPMorgan Chase & Co. General Counsel Stacey Friedman reported an indirect sale of common stock through a grantor retained annuity trust (GRAT). On February 17, 2026, the GRAT sold 3,404 shares at $306.3999 per share in an open-market transaction.
Following this sale, the GRAT held 61,949 shares of JPMorgan Chase common stock indirectly for Friedman. Separately, she held 50,136 shares directly, and an additional 13,604 shares were held indirectly in a trust.
JPMorgan Chase insider Stacey Friedman has filed a Form 144 indicating an intent to sell 3,404 shares of common stock. The planned sale, through J.P. Morgan Securities LLC on the NYSE, has an aggregate market value of 1,042,985.11 based on the filing.
The shares to be sold were originally acquired on 03/25/2022 as equity compensation awards from the issuer. The filing also notes a prior sale of 3,404 shares of common stock on 01/16/2026, which generated gross proceeds of 1,064,758. Shares outstanding were 2,696,272,576 as of the figures used in the notice.
A shareholder filed a Form 144 notice to sell 3,907 shares of common stock, with an aggregate market value of $1,197,158.15. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE around 02/17/2026. These shares were acquired on 01/13/2022 as equity compensation awards from the issuer. The filer also sold 3,908 shares of the same common stock on 01/16/2026 for gross proceeds of $1,222,353.41, as disclosed for sales during the past three months.
Douglas Petno filed a Form 144 notice to sell 3,487 shares of JPM common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $1,068,428.91. The filing lists 2,696,272,576 shares of common stock outstanding.
The shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer. The notice also reports that during the past three months, Petno sold 3,487 shares of common stock on 01/16/2026 for gross proceeds of $1,090,727.70.
JPM common stock holder Mary Erdoes filed a notice to sell 5,731 shares of common stock, with an aggregate market value of $1,756,045.86, through J.P. Morgan Securities LLC on or about 02/17/2026 on the NYSE. The filing lists 2,696,272,576 common shares outstanding.
The 5,731 shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer. Over the prior three months, Erdoes sold 5,732 shares of the same common stock on 01/16/2026 for gross proceeds of $1,792,878.56.
JPMorgan Chase investor plans a small insider sale. A holder intends to sell 2,047 shares of JPMorgan Chase common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of February 17, 2026 and an aggregate market value of 627,207.13.
The shares were acquired on January 13, 2026 as equity compensation awards from the issuer. The filing also notes that a person named Lori Beer sold 2,047 common shares on January 16, 2026, generating gross proceeds of 640,295.04.
JPMorgan Chase insider plans and reports stock sales. A Form 144 notice covers a proposed sale of 2,892 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $886,156.96, against 2,696,272,576 shares outstanding.
The shares were acquired on January 13, 2026 as equity compensation from the issuer. The filing also notes that Jeremy Barnum sold 2,893 shares of $1 par value common stock on January 16, 2026 for gross proceeds of $904,889.57. The filer represents they are not aware of undisclosed material adverse information.
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering auto callable yield notes linked to the worst performer of Broadcom, Eli Lilly and Micron common stock. The notes pay at least 20.00% per annum, credited monthly, as long as they remain outstanding.
The notes may be automatically called on scheduled review dates starting in August 2026 if each stock is at or above its initial price, returning $1,000 per note plus the applicable interest. If not called, principal repayment at maturity in August 2027 depends on the weakest stock: as long as each final stock price is at least 50.00% of its initial value, investors receive full principal plus the final interest payment.
If any stock finishes below its 50.00% trigger, principal is reduced one-for-one with the decline of the worst stock, and investors can lose more than half, up to all, of their investment. The notes are unsecured obligations subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co. An example estimated value is $962.20 per $1,000 note, and the final estimated value will not be less than $900.00.
JPMorgan Chase Financial Company LLC is offering five-year Trigger GEARS, unsecured notes linked to an unequally weighted basket of six major equity indices: S&P 500 (45%), EURO STOXX 50 (22%), Nikkei 225 (13.75%), FTSE 100 (9.63%), Swiss Market Index (5.50%) and S&P/ASX 200 (4.13%).
The notes are issued at $10 per Security, in $10 increments with a $1,000 minimum, and pay no interest or dividends. At maturity, if the basket has risen, investors receive $10 plus the basket return multiplied by an Upside Gearing between 1.15 and 1.30. If the basket is flat or down but still at or above 75% of its initial basket value, principal is repaid. If the basket falls below that 75% downside threshold, repayment is reduced dollar-for-dollar with the negative basket return, and investors can lose all principal.
The notes are fully and unconditionally guaranteed by JPMorgan Chase & Co., but payments depend on the credit of both issuer and guarantor. The public issue price is $10.00, including up to $0.35 per $10 in selling commissions to UBS, while the indicative estimated value is about $9.48 per $10 (and will not be less than $9.10), reflecting embedded structuring and hedging costs.